201 related articles for article (PubMed ID: 14572138)
1. Molecular basis of Canavan's disease: from human to mouse.
Surendran S; Matalon KM; Tyring SK; Matalon R
J Child Neurol; 2003 Sep; 18(9):604-10. PubMed ID: 14572138
[TBL] [Abstract][Full Text] [Related]
2. Metabolic changes in the knockout mouse for Canavan's disease: implications for patients with Canavan's disease.
Surendran S; Matalon KM; Szucs S; Tyring SK; Matalon R
J Child Neurol; 2003 Sep; 18(9):611-5. PubMed ID: 14572139
[TBL] [Abstract][Full Text] [Related]
3. Canavan disease: studies on the knockout mouse.
Matalon R; Michals-Matalon K; Surendran S; Tyring SK
Adv Exp Med Biol; 2006; 576():77-93; discussion 361-3. PubMed ID: 16802706
[TBL] [Abstract][Full Text] [Related]
4. Mild-onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase gene.
Janson CG; Kolodny EH; Zeng BJ; Raghavan S; Pastores G; Torres P; Assadi M; McPhee S; Goldfarb O; Saslow B; Freese A; Wang DJ; Bilaniuk L; Shera D; Leone P
Ann Neurol; 2006 Feb; 59(2):428-31. PubMed ID: 16437572
[TBL] [Abstract][Full Text] [Related]
5. Novel mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
Unalp A; Altiok E; Uran N; Oztürk A; Yüksel S
J Trop Pediatr; 2008 Jun; 54(3):208-10. PubMed ID: 17999961
[TBL] [Abstract][Full Text] [Related]
6. Canavan disease: a monogenic trait with complex genomic interaction.
Surendran S; Michals-Matalon K; Quast MJ; Tyring SK; Wei J; Ezell EL; Matalon R
Mol Genet Metab; 2003; 80(1-2):74-80. PubMed ID: 14567959
[TBL] [Abstract][Full Text] [Related]
7. Spongy degeneration of the brain, Canavan disease: biochemical and molecular findings.
Matalon RM; Michals-Matalon K
Front Biosci; 2000 Mar; 5():D307-11. PubMed ID: 10704428
[TBL] [Abstract][Full Text] [Related]
8. Canavan disease: diagnosis and molecular analysis.
Matalon R
Genet Test; 1997; 1(1):21-5. PubMed ID: 10464621
[TBL] [Abstract][Full Text] [Related]
9. Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease.
Madhavarao CN; Arun P; Moffett JR; Szucs S; Surendran S; Matalon R; Garbern J; Hristova D; Johnson A; Jiang W; Namboodiri MA
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5221-6. PubMed ID: 15784740
[TBL] [Abstract][Full Text] [Related]
10. Homozygosity for mutation G212A of the gene for aspartoacylase is associated with atypical form of Canavan's disease.
Velinov M; Zellers N; Styles J; Wisniewski K
Clin Genet; 2008 Mar; 73(3):288-9. PubMed ID: 18070137
[No Abstract] [Full Text] [Related]
11. A mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
Eke GH; Iscan A; Cece H; Calik M
Genet Couns; 2012; 23(1):9-12. PubMed ID: 22611636
[TBL] [Abstract][Full Text] [Related]
12. Use of localized proton nuclear magnetic resonance spectroscopy in Canavan's disease.
Aydinli N; Calişkan M; Calay M; Ozmen M
Turk J Pediatr; 1998; 40(4):549-57. PubMed ID: 10028864
[TBL] [Abstract][Full Text] [Related]
13. Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system.
Matalon R; Rady PL; Platt KA; Skinner HB; Quast MJ; Campbell GA; Matalon K; Ceci JD; Tyring SK; Nehls M; Surendran S; Wei J; Ezell EL; Szucs S
J Gene Med; 2000; 2(3):165-75. PubMed ID: 10894262
[TBL] [Abstract][Full Text] [Related]
14. Canavan's spongiform leukodystrophy: a clinical anatomy of a genetic metabolic CNS disease.
Baslow MH
J Mol Neurosci; 2000 Oct; 15(2):61-9. PubMed ID: 11220786
[TBL] [Abstract][Full Text] [Related]
15. Mild elevation of N-acetylaspartic acid and macrocephaly: diagnostic problem.
Surendran S; Bamforth FJ; Chan A; Tyring SK; Goodman SI; Matalon R
J Child Neurol; 2003 Nov; 18(11):809-12. PubMed ID: 14696913
[TBL] [Abstract][Full Text] [Related]
16. Computational analysis of deleterious missense mutations in aspartoacylase that cause Canavan's disease.
Sreevishnupriya K; Chandrasekaran P; Senthilkumar A; Sethumadhavan R; Shanthi V; Daisy P; Nisha J; Ramanathan K; Rajasekaran R
Sci China Life Sci; 2012 Dec; 55(12):1109-19. PubMed ID: 23233226
[TBL] [Abstract][Full Text] [Related]
17. The Clinical Features and Diagnosis of Canavan's Disease: A Case Series of Iranian Patients.
Karimzadeh P; Jafari N; Nejad Biglari H; Rahimian E; Ahmadabadi F; Nemati H; Nasehi MM; Ghofrani M; Mollamohammadi M
Iran J Child Neurol; 2014; 8(4):66-71. PubMed ID: 25657773
[TBL] [Abstract][Full Text] [Related]
18. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease.
Kaul R; Gao GP; Balamurugan K; Matalon R
Nat Genet; 1993 Oct; 5(2):118-23. PubMed ID: 8252036
[TBL] [Abstract][Full Text] [Related]
19. Mutation detection in the aspartoacylase gene in 17 patients with Canavan disease: four new mutations in the non-Jewish population.
Sistermans EA; de Coo RF; van Beerendonk HM; Poll-The BT; Kleijer WJ; van Oost BA
Eur J Hum Genet; 2000 Jul; 8(7):557-60. PubMed ID: 10909858
[TBL] [Abstract][Full Text] [Related]
20. A novel aspartoacylase (ASPA) gene mutation in Canavan disease.
Durmaz AA; Akin H; Onay H; Vahabi A; Ozkinay F
Fetal Pediatr Pathol; 2012 Aug; 31(4):236-9. PubMed ID: 22468686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
